Repository logo
  • English
  • Latviešu
  • Log In
    New user? Click here to register. Have you forgotten your password?
Repository logo
  • Communities & Collections
  • All of DSpace
  • English
  • Latviešu
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Vecvagare, Katrīne"

Now showing 1 - 2 of 2
Results Per Page
Sort Options
  • No Thumbnail Available
    Item
    Does the course of disease influence the development of fatigue in rheumatoid arthritis patients?
    (2021-04-01) Kadiša, Anda; Nora-Krūkle, Zaiga; Sokolovska, Lība; Grāvelsiņa, Sabīne; Vecvagare, Katrīne; Svirskis, Šimons; Lejnieks, Aivars; Murovska, Modra; Department of Internal Diseases; Institute of Microbiology and Virology
    Patients with rheumatoid arthritis (RA) typically have many permanently inflamed joints. The inflammation inside the body can lead to general physical weakness, exhaustion, and drowsiness. This feeling of extreme tiredness is also called “fatigue”. Some people find this to be the worst symptom of the disease. However, the clinical significance of fatigue and its pathogenesis have not been recognised. This study aimed to determine the development of fatigue depending on activity and aggressiveness of RA. To achieve the goal, patients were interviewed and indicators of disease activity and aggressiveness were determined: rheumatoid factor (RF), anti-cyclic citrullinated peptide antibodies (anti-CCP), erythrocyte sedimentation rate (ESR), C reactive protein (CRP), immunoglobulins IgA RF, IgM RF, IgG RF and anti-carbamylated protein antibodies (anti-CarP). Based on the results of the survey, RA patients were divided into two groups - with and without fatigue. In the group of RA patients with fatigue, statistically more often an increase in IgA RF, IgM RF, and IgG RF levels was observed in those with elevated RF level, higher IgM RF and IgG RF levels were associated with increase in IgA RF level, and increase in the IgG RF and anti-CarP levels with elevation in the IgM RF level. A higher IgG RF level contributed to a higher anti-CarP level increase. Significant differences in the levels of clinical and laboratory inflammatory markers were not observed between the RA patients with and without fatigue. The obtained data suggest that the aggressive course of RA, more than inflammation, may contribute to the development of fatigue in RA patients.
  • No Thumbnail Available
    Item
    Severity of COVID-19 : Causes and Consequences — From Obesity to Chronic Fatigue Syndrome
    (2021-12-14) Arāja, Diāna; Rovīte, Vita; Murovska, Modra; Terentjeva, Anna; Vaidere, Diāna; Vecvagare, Katrīne; Vīksna, Ludmila; Institute of Microbiology and Virology; Rīga Stradiņš University
    In circumstances of COVID-19 epidemiological uncertainty, the causes and consequences of the disease remain important issues. The aim of this study was to investigate obesity as a potential predisposition and chronic fatigue syndrome (CFS) as a possible consequence of COVID-19. The study was conducted in two parts: a theoretical part, in which a literature review was performed, and an empirical part, in which COVID-19 patient survey data were analysed. To identify the main findings regarding the relationship between obesity and COVID-19, the literature review was focused on the investigation of systematic reviews and meta-analyses by three databases — Med-line (via PubMed), Cochrane COVID-19 Study Register, and PROSPERO (International prospective register of systematic reviews). The patient survey was performed to investigate the relationship between obesity and severity of the disease, as well as the presence of CFS symptoms in COVID-19 patients in Latvia. The main findings of the literature review showed that obesity increases the risk of hospitalisation, disease severity, clinical complications, poor outcomes, and mortality. The results of the patient survey showed that overweight and obesity were more critical factors for men (males) suffering with COVID-19 than for women (females) in Latvia. The patient group with obesity caused almost half of all hospitalisations. The research data assumed that CFS patients were not a high-risk group for COVID-19, but COVID-19 caused CFS-like symptoms in patients and potentially increased the number of undiagnosed patients. In the context of further epidemiological uncertainty and the possibility of severe post-viral consequences, preventive measures are becoming increasingly important.

DSpace software copyright © 2002-2025 LYRASIS

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback